Pacific Edge Launches NZ$24 Million Capital Raise

MT Newswires Live

May 11

Pacific Edge (ASX:PEB, NZE:PEB) launched a capital raising of up to NZ$24 million comprising an NZ$18 million institutional placement and a NZ$6 million retail offer at NZ$0.17 per share, according to a Monday filing with the Australian and New Zealand bourses.

The offer price reflects a 2% discount to the stock's five-day volume-weighted average price.

The capital raising is intended to provide the company with the resources needed to restore Medicare coverage, secure reimbursement for its tests, and support the company's growth strategy, per the filing.

The company reported unaudited fiscal 2026 revenue of NZ$11.5 million, down from NZ$21.8 million in fiscal 2025 after Medicare ended reimbursement coverage of Cxbladder, reducing US testing volumes and increasing net loss to NZ$35.7 million compared with NZ$29.9 million in the prior year, the filing said.

The company said it expects an update from the Medicare administrative contractor Novitas before September, including a draft local coverage determination that may restore coverage for Cxbladder Triage tests and enhance revenue potential and commercial payer adoption.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/2634642170"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2634642170\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2634642170?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-11 06:14","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2634642170","market":"sg","top_or_hot":-1,"title":"Pacific Edge Launches NZ$24 Million Capital Raise","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/PFGTF\">Pacific Edge</a> (ASX:PEB, NZE:PEB) launched a capital raising of up to NZ$24 million comprising an NZ$18 million institutional placement and a NZ$6 million retail offer at NZ$0.17 per share, according to a Monday filing with the Australian and New Zealand bourses.</p><p>The offer price reflects a 2% discount to the stock's five-day volume-weighted average price.</p><p>The capital raising is intended to provide the company with the resources needed to restore Medicare coverage, secure reimbursement for its tests, and support the company's growth strategy, per the filing.</p><p>The company reported unaudited fiscal 2026 revenue of NZ$11.5 million, down from NZ$21.8 million in fiscal 2025 after Medicare ended reimbursement coverage of Cxbladder, reducing US testing volumes and increasing net loss to NZ$35.7 million compared with NZ$29.9 million in the prior year, the filing said.</p><p>The company said it expects an update from the Medicare administrative contractor Novitas before September, including a draft local coverage determination that may restore coverage for Cxbladder Triage tests and enhance revenue potential and commercial payer adoption.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pacific Edge Launches NZ$24 Million Capital Raise</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPacific Edge Launches NZ$24 Million Capital Raise\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-05-11 06:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> <a href=\"https://laohu8.com/S/PFGTF\">Pacific Edge</a> (ASX:PEB, NZE:PEB) launched a capital raising of up to NZ$24 million comprising an NZ$18 million institutional placement and a NZ$6 million retail offer at NZ$0.17 per share, according to a Monday filing with the Australian and New Zealand bourses.</p><p>The offer price reflects a 2% discount to the stock's five-day volume-weighted average price.</p><p>The capital raising is intended to provide the company with the resources needed to restore Medicare coverage, secure reimbursement for its tests, and support the company's growth strategy, per the filing.</p><p>The company reported unaudited fiscal 2026 revenue of NZ$11.5 million, down from NZ$21.8 million in fiscal 2025 after Medicare ended reimbursement coverage of Cxbladder, reducing US testing volumes and increasing net loss to NZ$35.7 million compared with NZ$29.9 million in the prior year, the filing said.</p><p>The company said it expects an update from the Medicare administrative contractor Novitas before September, including a draft local coverage determination that may restore coverage for Cxbladder Triage tests and enhance revenue potential and commercial payer adoption.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK8033","symbol_name":"生物科技","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2634642170","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2634642170","pubTimestamp":1778451294,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Pacific Edge  launched a capital raising of up to NZ$24 million comprising an NZ$18 million institutional placement and a NZ$6 million retail offer at NZ$0.17 per share, according to a Monday filing with the Australian and New Zealand bourses.The offer price reflects a 2% discount to the stock's five-day volume-weighted average price.The capital raising is intended to provide the company with the resources needed to restore Medicare coverage, secure reimbursement for its tests, and support the company's growth strategy, per the filing.The company reported unaudited fiscal 2026 revenue of NZ$11.5 million, down from NZ$21.8 million in fiscal 2025 after Medicare ended reimbursement coverage of Cxbladder, reducing US testing volumes and increasing net loss to NZ$35.7 million compared with NZ$29.9 million in the prior year, the filing said.The company said it expects an update from the Medicare administrative contractor Novitas before September, including a draft local coverage determinatio","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK8033":"生物科技","PEB.NZ":"Pacific Edge Limited Ordinary Shares","PEB.AU":"PACIFIC EDGE LTD","BK7067":"生物科技"},"translate_title":"Pacific Edge启动2400万新西兰元融资","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PEB.NZ":1.5,"PEB.AU":1},"content_text":"Pacific Edge (ASX:PEB, NZE:PEB) launched a capital raising of up to NZ$24 million comprising an NZ$18 million institutional placement and a NZ$6 million retail offer at NZ$0.17 per share, according to a Monday filing with the Australian and New Zealand bourses.The offer price reflects a 2% discount to the stock's five-day volume-weighted average price.The capital raising is intended to provide the company with the resources needed to restore Medicare coverage, secure reimbursement for its tests, and support the company's growth strategy, per the filing.The company reported unaudited fiscal 2026 revenue of NZ$11.5 million, down from NZ$21.8 million in fiscal 2025 after Medicare ended reimbursement coverage of Cxbladder, reducing US testing volumes and increasing net loss to NZ$35.7 million compared with NZ$29.9 million in the prior year, the filing said.The company said it expects an update from the Medicare administrative contractor Novitas before September, including a draft local coverage determination that may restore coverage for Cxbladder Triage tests and enhance revenue potential and commercial payer adoption.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}